Reducing benzodiazepine consumption: psychological contributions to general practice
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York, NY [u.a.]
Springer
1989
|
| Schriftenreihe: | Recent Research in Psychology
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturverz. S. 85 - 94 |
| Beschreibung: | X, 96 S. graph. Darst. |
| ISBN: | 3540970355 0387970355 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV002460686 | ||
| 003 | DE-604 | ||
| 005 | 20150417 | ||
| 007 | t | ||
| 008 | 891106s1989 d||| |||| 00||| eng d | ||
| 020 | |a 3540970355 |9 3-540-97035-5 | ||
| 020 | |a 0387970355 |9 0-387-97035-5 | ||
| 035 | |a (OCoLC)19814868 | ||
| 035 | |a (DE-599)BVBBV002460686 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-473 |a DE-824 |a DE-188 | ||
| 050 | 0 | |a RM666.B42 | |
| 082 | 0 | |a 615/.7882 |2 20 | |
| 084 | |a CZ 2000 |0 (DE-625)19239: |2 rvk | ||
| 084 | |a XI 5815 |0 (DE-625)153018:12921 |2 rvk | ||
| 100 | 1 | |a Cormack, Margaret A. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Reducing benzodiazepine consumption |b psychological contributions to general practice |c Margaret A. Cormack ; R. Glynn Owens ; Michael E. Dewey |
| 264 | 1 | |a New York, NY [u.a.] |b Springer |c 1989 | |
| 300 | |a X, 96 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Recent Research in Psychology | |
| 500 | |a Literaturverz. S. 85 - 94 | ||
| 650 | 7 | |a Benzodiazepinen |2 gtt | |
| 650 | 7 | |a Ontwenning |2 gtt | |
| 650 | 7 | |a Verslaving |2 gtt | |
| 650 | 4 | |a Psychologie | |
| 650 | 4 | |a Benzodiazepines | |
| 650 | 4 | |a Benzodiazepines |x administration & dosage | |
| 650 | 4 | |a Benzodiazepines |x therapeutic use | |
| 650 | 4 | |a Chemotherapy |x Psychological aspects | |
| 650 | 4 | |a Drugs |x Dosage |x Reduction | |
| 650 | 4 | |a Medication abuse |x Prevention | |
| 650 | 4 | |a Patients |x Counseling of | |
| 650 | 4 | |a Substance-Related Disorders |x psychology | |
| 650 | 0 | 7 | |a Benzodiazepine |0 (DE-588)4005552-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychotherapie |0 (DE-588)4047746-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldosis |0 (DE-588)4214417-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelkonsum |0 (DE-588)4128983-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelmissbrauch |0 (DE-588)4139055-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittelmissbrauch |0 (DE-588)4139055-6 |D s |
| 689 | 0 | 1 | |a Prävention |0 (DE-588)4076308-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Benzodiazepine |0 (DE-588)4005552-8 |D s |
| 689 | 1 | 1 | |a Arzneimitteldosis |0 (DE-588)4214417-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Benzodiazepine |0 (DE-588)4005552-8 |D s |
| 689 | 2 | 1 | |a Psychotherapie |0 (DE-588)4047746-0 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Benzodiazepine |0 (DE-588)4005552-8 |D s |
| 689 | 3 | 1 | |a Arzneimittelkonsum |0 (DE-588)4128983-3 |D s |
| 689 | 3 | |5 DE-604 | |
| 700 | 1 | |a Owens, Richard Glynn |e Verfasser |4 aut | |
| 700 | 1 | |a Dewey, Michael E. |e Verfasser |4 aut | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001591009&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001591009 | ||
Datensatz im Suchindex
| _version_ | 1804116875662065664 |
|---|---|
| adam_text | R 3 MARGARET A. CORMACK R. GLYNN OWENS MICHAEL E. DEWEY REDUCING
BENZODIAZEPINE CONSUMPTION PSYCHOLOGICAL CONTRIBUTIONS TO GENERAL
PRACTICE SPRINGER-VERLAG NEW YORK BERLIN HEIDELBERG LONDON PARIS TOKYO
HONG KONG CONTENTS PART ONE: BACKGROUND TO THE STUDY INTRODUCTION 1
LITERATURE REVIEW 1. INTRODUCTION 3 2. THE BENZODIAZEPINES 3 2.1 HISTORY
OF THE BENZODIAZEPINES 3 2.2 PHARMACOLOGICAL ACTION OF THE
BENZODIAZEPINES 4 2.3 DIFFERENT TYPES OF BENZODIAZEPINES 5 2.4 THE
THERAPEUTIC EFFECT OF THE BENZODIAZEPINES 7 A) USE AS ANXIOLYTICS 7 B)
USE AS HYPNOTICS 8 C) BENZODIAZEPINES AS THERAPY FOR DEPRESSION 9 D) USE
OF BENZODIAZEPINES IN PHYSICAL ILLNESS 9 E) PARADOXICAL DRUG REACTIONS
10 2.5 EFFECTS OF BENZODIAZEPINES ON PERFORMANCE 11 A) EFFECTS IN NORMAL
AND ANXIOUS SUBJECTS 11 B) DECREMENTS PRODUCED BY HYPNOTICS 13 C)
COGNITIVE IMPAIRMENTS 13 D) EFFECTS ON THE ELDERLY 14 3. PRESCRIBING 14
3.1 TRENDS IN PRESCRIBING 14 3.2 EXTENT OF USE OF THE BENZODIAZEPINES 15
3.3 SEX DIFFERENCES IN THE USE OF BENZODIAZEPINES 18 3.4 BENZODIAZEPINE
CONSUMPTION IN THE ELDERLY .* 21 3.5 CLASS AND EMPLOYMENT DIFFERENCES IN
BENZODIAZEPINE USE 22 3.6 REASONS FOR THE PRESCRIPTION 23 3.7 REPEAT
PRESCRIBING 24 3.8 EXPECTATIONS OF PATIENTS 25 4. DEPENDENCE 26 4.1
DEFINITIONS OF DEPENDENCE *. 26 4.2 TOLERANCE 27 4.3 WITHDRAWAL 27 4.4
CHARACTERISTICS OF LONG-TERM USERS OF BENZODIAZEPINES 30 5. ALTERNATIVES
TO BENZODIAZEPINE MEDICATION 32 5.1 PSYCHOLOGICAL THERAPY AS AN
ALTERNATIVE TO MEDICATION 32 5.2 CHANGES IN PATTERNS OF LONG-TERM USE OF
BENZODIAZEPINES 33 6. SUMMARY 34 PART TWO: A STUDY OF DRUG REDUCTION
AIMS OF THE RESEARCH 35 OUTLINE OF THE STUDY 1. GENERAL PRACTITIONER
INTERVENTION 36 1.1 POPULATION 36 1.2 IDENTIFICATION OF THE SAMPLE 36
1.3 CRITERIA FOR SELECTION OF THE PATIENTS 36 1.4 THE PRACTICES 37 1.5
THE EXPERIMENT 38 1.6 ALLOCATION OF PATIENTS TO GROUPS 38 1.7
INTERVENTIONS 39 A) LETTER 39 B) INTERVIEW 40 C) CONTROL 40 1.8
CALCULATION OF TABLET EQUIVALENCE 41 2. INTERVIEW WITH THE PSYCHOLOGIST
41 3. GROUP WORK IN PSYCHOLOGICAL ALTERNATIVES 41 3.1 CONTRACTS 41 3.2
DURATION OF THE GROUP 42 3.3 CONTENT OF GROUP WORK 42 3.4 HOMEWORK TASKS
43 3.5 TABLET WITHDRAWAL 44 3.6 APPLICATION OF STRATEGIES 45 4. SUMMARY
45 RESULTS 1. SUBJECTS 46 1.1 CHARACTERISTICS OF SUBJECTS AND PRACTICES
! 46 1.2 AGE OF THE SAMPLE 46 2. MEDICATION 47 2.1 DURATION OF
MEDICATION 48 2.2 BASELINE NUMBER OF TABLETS 48 3. THE PRACTICES 49
DESCRIPTION OF THE PRACTICES 49 4. GROUPS 50 4.1 ALLOCATION OF SUBJECTS
TO GROUPS 50 4.2 DIFFERENCES AMONG THE GROUPS 50 4.3 ALLOCATION OF
CONTROL SUBJECTS TO INTERVENTION GROUPS 51 4.4 SUMMARY 51 VLLL 5.
ANALYSIS OF CHANGE OVER TIME IN DRUG TAKING 52 5.1 CONTROL GROUP 53 5.2
INTERVENTION GROUPS 53 5.2.1 CHANGES OVER THE FIRST SIX MONTHS 54 5.2.2
COMPARISON OF BASELINE WITH MONTHS SEVEN TO TWELVE OF MONITORING 56
5.2.3 COMPARISON OF BASELINE WITH CONSUMPTION IN THE SECOND YEAR OF
MONITORING 56 6. OCCURRENCE OF MAJOR CHANGE 57 6.1 CHANGES OVER THE
SECOND SIX MONTHS 58 6.2 COMPARISON OF CONSUMPTION IN MONTHS SEVEN TO
TWELVE WITH THE SECOND YEAR OF MONITORING 59 7. FACTORS RELATING TO
SUCCESSFUL DRUG REDUCTION 59 7.1 DIFFERENCES BETWEEN THE SUCCESSFUL
SUBJECTS AND THOSE NOT SUCCESSFUL 60 7.2 OTHER FACTORS RELATED TO
SUCCESS , 61 8. THE PSYCHOLOGY INTERVIEW 62 8.1 NUMBERS OF PATIENTS
ATTENDING THE PSYCHOLOGY INTERVIEW 62 8.2 DIFFERENCES BETWEEN ATTENDERS
AND NON-ATTENDERS 62 8.3 TIME OF DAY TABLETS TAKEN 63 8.4 STRATEGIES
EMPLOYED TO REDUCE MEDICATION 64 8.5 FACTORS LINKED TO SUCCESSFUL
STOPPING OF MEDICATION 65 8.6 SUMMARY 65 9. GENERAL SUMMARY OF FINDINGS
66 10. GROUP PSYCHOLOGICAL THERAPY 67 10.1 FORMATION OF THE GROUPS 67
10.2 CHANGES IN CONSUMPTION OVER THE COURSE OF THE GROUP 68 10.3 SUMMARY
OF CHANGES IN OTHER MEDICATION 71 10.4 SUMMARY OF OUTCOME OF GROUP
THERAPY 71 10.5 STRATEGIES EMPLOYED BY THE GROUP MEMBERS FOR TABLET
REDUCTION 72 10.6 SUMMARY 72 DISCUSSION 1. SEX-RATIO OF SUBJECTS }. 73
2. AGE OF SUBJECTS :. 73 3. BASELINE TABLET CONSUMPTION 73 4. GROUP
DIFFERENCES 74 5. LOW ATTENDANCE AT THE PSYCHOLOGY INTERVIEW 74 6. LACK
OF INTEREST IN GROUP THERAPY 75 7. WITHDRAWAL FROM DIAZEPAM AND
LORAZEPAM 75 8. DIFFERENCES IN SUCCESS WHEN TAKING SINGLE OR COMBINED
BENZODIAZEPINES 75 9. REASONS FOR THE SUCCESS OF THE DOCTORS
INTERVENTIONS 76 10. EFFECT OF A DECREASE IN BENZODIAZEPINES ON ALCOHOL
AND TOBACCO CONSUMPTION 76 11. DIFFERENCES BETWEEN THE FACTORS LEADING
TO THE INITIAL PRESCRIPTION OF BENZODIAZEPINES AND THOSE WHICH
MAINTAINED THE DRUG CONSUMPTION 77 12. STRATEGIES DEVISED BY THE
PATIENTS LEADING TO SUCCESS IN STOPPING MEDICATION 78 13. EFFECT OF THE
GROUP PSYCHOLOGICAL THERAPY ON TABLET CONSUMPTION 78 14. COMPONENTS OF
THE PSYCHOLOGICAL THERAPY WHICH WERE MOST USEFUL FOR PATIENTS 78 IX
COMMENTS ON THE WOFK 1. METHODOLOGICAL CONSIDERATIONS OF THE PRESENT
STUDY 80 1.1 LIMITATIONS OF THE INTERVIEW DATA 80 1.2 FUTURE EXPANSION
OF THE INTERVIEW 80 1.3 CONTROL OF MEDICATION IN THE HOSPITAL GROUPS 81
2. IMPLICATIONS OF THE STUDY 81 2.1 BENEFITS FOR THE PATIENTS 81 2.2
COST BENEFITS 81 3. FUTURE WORK 82 3.1 THE USE OF BIBLIOTHERAPY 82 3.2
EXPANSION OF INCLUSION CRITERIA 83 3.3 PSYCHOLOGY CONTRIBUTION 84
REFERENCES 85 APPENDIX 95
|
| any_adam_object | 1 |
| author | Cormack, Margaret A. Owens, Richard Glynn Dewey, Michael E. |
| author_facet | Cormack, Margaret A. Owens, Richard Glynn Dewey, Michael E. |
| author_role | aut aut aut |
| author_sort | Cormack, Margaret A. |
| author_variant | m a c ma mac r g o rg rgo m e d me med |
| building | Verbundindex |
| bvnumber | BV002460686 |
| callnumber-first | R - Medicine |
| callnumber-label | RM666 |
| callnumber-raw | RM666.B42 |
| callnumber-search | RM666.B42 |
| callnumber-sort | RM 3666 B42 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | CZ 2000 XI 5815 |
| ctrlnum | (OCoLC)19814868 (DE-599)BVBBV002460686 |
| dewey-full | 615/.7882 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.7882 |
| dewey-search | 615/.7882 |
| dewey-sort | 3615 47882 |
| dewey-tens | 610 - Medicine and health |
| discipline | Psychologie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02888nam a2200733 c 4500</leader><controlfield tag="001">BV002460686</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150417 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">891106s1989 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540970355</subfield><subfield code="9">3-540-97035-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0387970355</subfield><subfield code="9">0-387-97035-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)19814868</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002460686</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.B42</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.7882</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CZ 2000</subfield><subfield code="0">(DE-625)19239:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5815</subfield><subfield code="0">(DE-625)153018:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cormack, Margaret A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Reducing benzodiazepine consumption</subfield><subfield code="b">psychological contributions to general practice</subfield><subfield code="c">Margaret A. Cormack ; R. Glynn Owens ; Michael E. Dewey</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 96 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Recent Research in Psychology</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 85 - 94</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Benzodiazepinen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ontwenning</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Verslaving</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benzodiazepines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benzodiazepines</subfield><subfield code="x">administration & dosage</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benzodiazepines</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemotherapy</subfield><subfield code="x">Psychological aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Dosage</subfield><subfield code="x">Reduction</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medication abuse</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patients</subfield><subfield code="x">Counseling of</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield><subfield code="x">psychology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Benzodiazepine</subfield><subfield code="0">(DE-588)4005552-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychotherapie</subfield><subfield code="0">(DE-588)4047746-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldosis</subfield><subfield code="0">(DE-588)4214417-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelkonsum</subfield><subfield code="0">(DE-588)4128983-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmissbrauch</subfield><subfield code="0">(DE-588)4139055-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelmissbrauch</subfield><subfield code="0">(DE-588)4139055-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Benzodiazepine</subfield><subfield code="0">(DE-588)4005552-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimitteldosis</subfield><subfield code="0">(DE-588)4214417-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Benzodiazepine</subfield><subfield code="0">(DE-588)4005552-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Psychotherapie</subfield><subfield code="0">(DE-588)4047746-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Benzodiazepine</subfield><subfield code="0">(DE-588)4005552-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Arzneimittelkonsum</subfield><subfield code="0">(DE-588)4128983-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Owens, Richard Glynn</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dewey, Michael E.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001591009&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001591009</subfield></datafield></record></collection> |
| id | DE-604.BV002460686 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:45:28Z |
| institution | BVB |
| isbn | 3540970355 0387970355 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001591009 |
| oclc_num | 19814868 |
| open_access_boolean | |
| owner | DE-12 DE-473 DE-BY-UBG DE-824 DE-188 |
| owner_facet | DE-12 DE-473 DE-BY-UBG DE-824 DE-188 |
| physical | X, 96 S. graph. Darst. |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| publisher | Springer |
| record_format | marc |
| series2 | Recent Research in Psychology |
| spelling | Cormack, Margaret A. Verfasser aut Reducing benzodiazepine consumption psychological contributions to general practice Margaret A. Cormack ; R. Glynn Owens ; Michael E. Dewey New York, NY [u.a.] Springer 1989 X, 96 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Recent Research in Psychology Literaturverz. S. 85 - 94 Benzodiazepinen gtt Ontwenning gtt Verslaving gtt Psychologie Benzodiazepines Benzodiazepines administration & dosage Benzodiazepines therapeutic use Chemotherapy Psychological aspects Drugs Dosage Reduction Medication abuse Prevention Patients Counseling of Substance-Related Disorders psychology Benzodiazepine (DE-588)4005552-8 gnd rswk-swf Psychotherapie (DE-588)4047746-0 gnd rswk-swf Arzneimitteldosis (DE-588)4214417-6 gnd rswk-swf Arzneimittelkonsum (DE-588)4128983-3 gnd rswk-swf Arzneimittelmissbrauch (DE-588)4139055-6 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf Arzneimittelmissbrauch (DE-588)4139055-6 s Prävention (DE-588)4076308-0 s DE-604 Benzodiazepine (DE-588)4005552-8 s Arzneimitteldosis (DE-588)4214417-6 s Psychotherapie (DE-588)4047746-0 s Arzneimittelkonsum (DE-588)4128983-3 s Owens, Richard Glynn Verfasser aut Dewey, Michael E. Verfasser aut GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001591009&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Cormack, Margaret A. Owens, Richard Glynn Dewey, Michael E. Reducing benzodiazepine consumption psychological contributions to general practice Benzodiazepinen gtt Ontwenning gtt Verslaving gtt Psychologie Benzodiazepines Benzodiazepines administration & dosage Benzodiazepines therapeutic use Chemotherapy Psychological aspects Drugs Dosage Reduction Medication abuse Prevention Patients Counseling of Substance-Related Disorders psychology Benzodiazepine (DE-588)4005552-8 gnd Psychotherapie (DE-588)4047746-0 gnd Arzneimitteldosis (DE-588)4214417-6 gnd Arzneimittelkonsum (DE-588)4128983-3 gnd Arzneimittelmissbrauch (DE-588)4139055-6 gnd Prävention (DE-588)4076308-0 gnd |
| subject_GND | (DE-588)4005552-8 (DE-588)4047746-0 (DE-588)4214417-6 (DE-588)4128983-3 (DE-588)4139055-6 (DE-588)4076308-0 |
| title | Reducing benzodiazepine consumption psychological contributions to general practice |
| title_auth | Reducing benzodiazepine consumption psychological contributions to general practice |
| title_exact_search | Reducing benzodiazepine consumption psychological contributions to general practice |
| title_full | Reducing benzodiazepine consumption psychological contributions to general practice Margaret A. Cormack ; R. Glynn Owens ; Michael E. Dewey |
| title_fullStr | Reducing benzodiazepine consumption psychological contributions to general practice Margaret A. Cormack ; R. Glynn Owens ; Michael E. Dewey |
| title_full_unstemmed | Reducing benzodiazepine consumption psychological contributions to general practice Margaret A. Cormack ; R. Glynn Owens ; Michael E. Dewey |
| title_short | Reducing benzodiazepine consumption |
| title_sort | reducing benzodiazepine consumption psychological contributions to general practice |
| title_sub | psychological contributions to general practice |
| topic | Benzodiazepinen gtt Ontwenning gtt Verslaving gtt Psychologie Benzodiazepines Benzodiazepines administration & dosage Benzodiazepines therapeutic use Chemotherapy Psychological aspects Drugs Dosage Reduction Medication abuse Prevention Patients Counseling of Substance-Related Disorders psychology Benzodiazepine (DE-588)4005552-8 gnd Psychotherapie (DE-588)4047746-0 gnd Arzneimitteldosis (DE-588)4214417-6 gnd Arzneimittelkonsum (DE-588)4128983-3 gnd Arzneimittelmissbrauch (DE-588)4139055-6 gnd Prävention (DE-588)4076308-0 gnd |
| topic_facet | Benzodiazepinen Ontwenning Verslaving Psychologie Benzodiazepines Benzodiazepines administration & dosage Benzodiazepines therapeutic use Chemotherapy Psychological aspects Drugs Dosage Reduction Medication abuse Prevention Patients Counseling of Substance-Related Disorders psychology Benzodiazepine Psychotherapie Arzneimitteldosis Arzneimittelkonsum Arzneimittelmissbrauch Prävention |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001591009&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT cormackmargareta reducingbenzodiazepineconsumptionpsychologicalcontributionstogeneralpractice AT owensrichardglynn reducingbenzodiazepineconsumptionpsychologicalcontributionstogeneralpractice AT deweymichaele reducingbenzodiazepineconsumptionpsychologicalcontributionstogeneralpractice |